News

LaMontagne will lead the commercial rollout of the company’s groundbreaking early-stage cancer detection test, Certitude.
Data from the 2021 National Health Interview Survey showed racial/ethnic differences in colorectal cancer screening were due to demographic and socioeconomic factors, except for low colonoscopy use in ...